Medical Engineering Technologies adds medtech testing space

Dover, UK-based Medical Engineering Technologies (MET) said it has begun expanding its lab capacity for ISO 10993-18 material characterization studies.

The company is adding more than 50% to its physical testing area for medical device adherence to the ISO 10993 series of standards, which apply when the material or device comes into contact with the body directly or indirectly.

The new laboratories will offer simulated use extraction, leachables and exhaustive extraction technologies combined with GC-MS, HPLC-MS, HPLC-TOF and many other analysis techniques for materials characterization. On the physical side, there will be an increased capacity for product performance testing. The testing may range from simple bond strength tests to dosing accuracy at varying atmospheric conditions.

Construction is underway and is scheduled for completion in February 2019. MET has been providing laboratory services to the medical device and pharmaceutical industries since 1997, including stability studies, sterile barrier studies, biocompatibility testing, bench testing, and product compliance analysis.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW